It started as a respiratory illness—or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...

Alex Berenson, a reporter who became a prominent vaccine skeptic during the COVID-19 pandemic, said that a Yale University study on long COVID and post-vaccination syndrome found the virus' spike ...

The spike protein of the coronavirus, or SARS-CoV-2, binds to ACE2, a receptor on the host cells, which allows the virus to enter the cells and infect it. Binding is the first step for infection, and ...

Based on this evidence, First Check determines that this viral video deceptively combines footage to falsely imply COVID ...

CLAIM: HIV is part of the composition of COVID-19 vaccinesFACT: False. An experimental vaccine developed by Professor Keith ...

It helped uncover previously undetectable distributions of spike protein in tissue samples from Covid-19 patients and mice. The study brought to light significantly elevated concentrations of spik ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

New study reveals how lingering spike protein in the brain's borders could explain long-term COVID-19 neurological symptoms and highlight vaccines' protective role. Study: Persistence of spike ...

Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from ...

Jason McLellan, molecular biosciences professor and Robert Welch chair in chemistry, and Barney Graham considered applying a ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...